Literature DB >> 12225755

L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin.

Natalia Davydova1, Victor Streltsov, Matthew Wilce, Anders Liljas, Maria Garber.   

Abstract

The ribosomal protein L22 is a core protein of the large ribosomal subunit interacting with all domains of the 23S rRNA. The triplet Met82-Lys83-Arg84 deletion in L22 from Escherichia coli renders cells resistant to erythromycin which is known as an inhibitor of the nascent peptide chain elongation. The crystal structure of the Thermus thermophilus L22 mutant with equivalent triplet Leu82-Lys83-Arg84 deletion has been determined at 1.8A resolution. The superpositions of the mutant and the wild-type L22 structures within the 50S subunits from Haloarcula marismortui and Deinococcus radiodurans show that the mutant beta-hairpin is bent inward the ribosome tunnel modifying the shape of its narrowest part and affecting the interaction between L22 and 23S rRNA. 23S rRNA nucleotides of domain V participating in erythromycin binding are located on the opposite sides of the tunnel and are brought to those positions by the interaction of the 23S rRNA with the L22 beta-hairpin. The mutation in the L22 beta-hairpin affects the orientation and distances between those nucleotides. This destabilizes the erythromycin-binding "pocket" formed by 23S rRNA nucleotides exposed at the tunnel surface. It seems that erythromycin, while still being able to interact with one side of the tunnel but not reaching the other, is therefore unable to block the polypeptide growth in the drug-resistant ribosome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225755     DOI: 10.1016/s0022-2836(02)00772-6

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  The extended loops of ribosomal proteins L4 and L22 are not required for ribosome assembly or L4-mediated autogenous control.

Authors:  Janice M Zengel; Adam Jerauld; Andre Walker; Markus C Wahl; Lasse Lindahl
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

2.  Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Cédric Cagliero; Christian Mouline; Axel Cloeckaert; Sophie Payot
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

3.  Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.

Authors:  Haihong Hao; Zonghui Yuan; Zhangqi Shen; Jing Han; Orhan Sahin; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

Review 4.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Phosphorylated proteins of the mammalian mitochondrial ribosome: implications in protein synthesis.

Authors:  Jennifer L Miller; Huseyin Cimen; Hasan Koc; Emine C Koc
Journal:  J Proteome Res       Date:  2009-10       Impact factor: 4.466

6.  Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22.

Authors:  Sean D Moore; Robert T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-17       Impact factor: 11.205

7.  In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.

Authors:  S Pereyre; C Guyot; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

8.  Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing.

Authors:  Tran Thanh Binh; Seiji Shiota; Rumiko Suzuki; Miyuki Matsuda; Tran Thi Huyen Trang; Dong Hyeon Kwon; Shun Iwatani; Yoshio Yamaoka
Journal:  J Antimicrob Chemother       Date:  2014-03-19       Impact factor: 5.790

9.  Bactobolin resistance is conferred by mutations in the L2 ribosomal protein.

Authors:  Josephine R Chandler; Thao T Truong; Patricia M Silva; Mohammad R Seyedsayamdost; Gavin Carr; Matthew Radey; Michael A Jacobs; Elizabeth H Sims; Jon Clardy; E Peter Greenberg
Journal:  MBio       Date:  2012-12-18       Impact factor: 7.867

Review 10.  Targeting Antibiotic Resistance.

Authors:  Mathieu F Chellat; Luka Raguž; Rainer Riedl
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-22       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.